β-galactosidase producing Lactiplantibacillus spp in intestinal microbiome mouse diarrhea model and metagenomic analyses

Mahanthesh Vasudha, Devaraja Gayathri
{"title":"β-galactosidase producing Lactiplantibacillus spp in intestinal microbiome mouse diarrhea model and metagenomic analyses","authors":"Mahanthesh Vasudha,&nbsp;Devaraja Gayathri","doi":"10.1016/j.microb.2024.100173","DOIUrl":null,"url":null,"abstract":"<div><div>Probiotics have attained significant interest in recent years as a result of their gut microbiome modulation and gastrointestinal health benefits. Numerous fermented foods contain LAB with <em>GRAS</em> grade and probiotic bacteria. The most promising isolates with high potentiality were selected for 16S rRNA gene sequence analysis and identified as <em>Lactiplantibacillus plantarum</em>, <em>L. fermentum</em>, <em>L. pentosus</em> and <em>Lactiplantibacillus</em> sp. The present study was conducted to determine the gastrointestinal symptoms after the consumption of milk and dairy products, lactose intolerance status using mice model. Post-weaning Balb/c mice were orally administered with probiotic bacteria to assess their efficiency in reducing lactose intolerance symptoms. They exhibited significantly reduced total feces weight and slower intestinal motility and they efficiently alleviated diarrhea symptoms within 6 h of lactose challenge in lactose intolerance-induced mice. Next generation sequence analysis was performed using intestinal content of model treated with <em>L. plantarum</em> GV54 and GV64, the intestinal bacterial diversity was studied using Illumina NGS analysis (16S rRNA hypervariable regions [V3 and V4]). NGS report confirmed the existence of the dominant phyla of the gut microbiome in mice are Bacteroidetes, Firmicutes and Proteobacteria. Due to the influence of the probiotic bacteria in the model group (GV54 and GV64), maximum abundance of phylum Firmicutes were observed when compared to the control group, whereas control group showed more abundance of phylum Bacteriodetes. However, the relative abundance of Bacteroidetes in the model group was decreased and Firmicutes abundance was increased. This indicates the genus abundance of <em>Lactobacillus</em> (<em>Lactiplantibacillus</em>) species or <em>Lactiplantibacillus plantarum</em> GV54 and GV64 bacteria. After treatment with probiotic bacteria <em>Lactobacillus</em> (<em>Lactiplantibacillus</em>) species, the probiotic bacterial abundance was increased consequently genera <em>Helicobacter, Clostridiales unclassified</em> and <em>Desulfovibrio</em> were decreased in the model groups. Probiotic bacteria has a positive impact on the regulation of intestinal microbial diversity in the tested mice system and it reflects that the intestinal microbiota of mice is dynamic and has positive impact on gut health. Considering this point, it is possible to promote <em>Lactiplantibacillus</em> spp. as probiotics and therapeutic food development at industrial scale.</div></div>","PeriodicalId":101246,"journal":{"name":"The Microbe","volume":"5 ","pages":"Article 100173"},"PeriodicalIF":0.0000,"publicationDate":"2024-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Microbe","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2950194624001407","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Probiotics have attained significant interest in recent years as a result of their gut microbiome modulation and gastrointestinal health benefits. Numerous fermented foods contain LAB with GRAS grade and probiotic bacteria. The most promising isolates with high potentiality were selected for 16S rRNA gene sequence analysis and identified as Lactiplantibacillus plantarum, L. fermentum, L. pentosus and Lactiplantibacillus sp. The present study was conducted to determine the gastrointestinal symptoms after the consumption of milk and dairy products, lactose intolerance status using mice model. Post-weaning Balb/c mice were orally administered with probiotic bacteria to assess their efficiency in reducing lactose intolerance symptoms. They exhibited significantly reduced total feces weight and slower intestinal motility and they efficiently alleviated diarrhea symptoms within 6 h of lactose challenge in lactose intolerance-induced mice. Next generation sequence analysis was performed using intestinal content of model treated with L. plantarum GV54 and GV64, the intestinal bacterial diversity was studied using Illumina NGS analysis (16S rRNA hypervariable regions [V3 and V4]). NGS report confirmed the existence of the dominant phyla of the gut microbiome in mice are Bacteroidetes, Firmicutes and Proteobacteria. Due to the influence of the probiotic bacteria in the model group (GV54 and GV64), maximum abundance of phylum Firmicutes were observed when compared to the control group, whereas control group showed more abundance of phylum Bacteriodetes. However, the relative abundance of Bacteroidetes in the model group was decreased and Firmicutes abundance was increased. This indicates the genus abundance of Lactobacillus (Lactiplantibacillus) species or Lactiplantibacillus plantarum GV54 and GV64 bacteria. After treatment with probiotic bacteria Lactobacillus (Lactiplantibacillus) species, the probiotic bacterial abundance was increased consequently genera Helicobacter, Clostridiales unclassified and Desulfovibrio were decreased in the model groups. Probiotic bacteria has a positive impact on the regulation of intestinal microbial diversity in the tested mice system and it reflects that the intestinal microbiota of mice is dynamic and has positive impact on gut health. Considering this point, it is possible to promote Lactiplantibacillus spp. as probiotics and therapeutic food development at industrial scale.
肠道微生物组小鼠腹泻模型中产β-半乳糖苷酶的乳杆菌属和元基因组分析
近年来,益生菌因其调节肠道微生物组和有益肠胃健康而备受关注。许多发酵食品都含有符合 GRAS 等级的 LAB 和益生菌。本研究利用小鼠模型确定食用牛奶和乳制品后的胃肠道症状以及乳糖不耐受状况。给断奶后的 Balb/c 小鼠口服益生菌,以评估其在减轻乳糖不耐受症状方面的功效。在乳糖不耐受诱导的小鼠中,益生菌可明显降低粪便总重量,减慢肠道蠕动,并在乳糖挑战后 6 小时内有效缓解腹泻症状。使用植物乳杆菌 GV54 和 GV64 处理的模型肠道内容物进行了下一代序列分析,并使用 Illumina NGS 分析(16S rRNA 超变区 [V3 和 V4])研究了肠道细菌的多样性。NGS 报告证实,小鼠肠道微生物组的优势菌系是类杆菌、固着菌和变形菌。由于模型组(GV54 和 GV64)益生菌的影响,与对照组相比,观察到固醇菌门的丰度最高,而对照组则显示出更高的类杆菌门丰度。然而,在模型组中,类杆菌属的相对丰度下降,而真菌门的丰度上升。这表明植物乳杆菌(Lactiplantibacillus)或植物乳杆菌 GV54 和 GV64 菌属的丰度较高。使用益生菌乳杆菌(Lactiplantibacillus)菌种处理后,模型组中益生菌的数量增加,而螺旋杆菌属、未分类梭状芽孢杆菌属和脱硫弧菌属的数量减少。益生菌对试验小鼠系统中肠道微生物多样性的调节有积极影响,这反映出小鼠肠道微生物群是动态的,对肠道健康有积极影响。考虑到这一点,有可能将 Lactiplantibacillus 菌属作为益生菌和治疗食品进行工业化开发。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信